randomized controlled trial, and uses a factorial 2 脳 2 design to determine the effects on macrovascular and microvascular outcomes of blood pressure-lowering (using an angiotensin-converting enzyme inhibitor and diuretic combination) and of intensive glucose control using a gliclazide MR-based regimen...